Quality-adjusted survival with combination nab-paclitaxel + gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis.
about
Treatment-related gastrointestinal toxicities and advanced colorectal or pancreatic cancer: A critical updateDilemma of first line regimens in metastatic pancreatic adenocarcinomaSurvival, quality-adjusted survival, and other clinical end points in older advanced non-small-cell lung cancer patients treated with albumin-bound paclitaxel.A Near-Complete Response to Treatment with Gemcitabine plus nab (®)-Paclitaxel in a Patient with Metastatic Pancreatic Cancer and Poor Performance Status: A Case Report.Prognostic factors of survival in patients treated with nab-paclitaxel plus gemcitabine regimen for advanced or metastatic pancreatic cancer: a single institutional experienceAlbumin-bound paclitaxel: a review of its use for the first-line combination treatment of metastatic pancreatic cancer.Cross-over comparison and new chemotherapy regimens in metastatic pancreatic cancer.Health-Related Quality of Life in Patients with Metastatic Pancreatic Cancer.Quality-adjusted survival with combination nal-IRI+5-FU/LV vs 5-FU/LV alone in metastatic pancreatic cancer patients previously treated with gemcitabine-based therapy: a Q-TWiST analysis.From First Line to Sequential Treatment in the Management of Metastatic Pancreatic Cancer.Health-related quality of life in a randomised phase III study of gemcitabine plus S-1, S-1 alone and gemcitabine alone for locally advanced or metastatic pancreatic cancer: GEST study.Performance status dynamics during treatment with nab-paclitaxel plus gemcitabine versus gemcitabine alone for metastatic pancreatic cancer.
P2860
Q26778004-C1889AB2-ED54-41E0-B92B-A7662D5A74E5Q28077147-F8B9FF55-97EA-440C-9578-A6D6461E55CFQ33423320-A9164DCC-5394-4321-8542-4774E4571106Q34632760-47D1613D-9D3D-4FF1-B208-A66152403C0EQ35781556-DA488FC7-F0CC-4A56-A50C-143EBC1B2403Q38254746-C32B453C-D7B4-4CCF-A7B6-AC2DB83E313AQ42361052-8F4701F6-6426-4A76-AB8C-B3CAD9077230Q45049735-6D07EA68-31AD-407E-B7C5-F194892F1135Q45055826-C26D18E3-120A-41D0-B0D2-2D3499E2C215Q55026515-FE665279-F1C0-4908-A01D-C4EC3CB0F74BQ55152175-691C5677-CB98-4CA2-95BA-A1E50532856BQ55364548-EEEB5A63-85C9-4604-AF15-6C4412B02484
P2860
Quality-adjusted survival with combination nab-paclitaxel + gemcitabine vs gemcitabine alone in metastatic pancreatic cancer: a Q-TWiST analysis.
description
2014 nî lūn-bûn
@nan
2014年の論文
@ja
2014年学术文章
@wuu
2014年学术文章
@zh
2014年学术文章
@zh-cn
2014年学术文章
@zh-hans
2014年学术文章
@zh-my
2014年学术文章
@zh-sg
2014年學術文章
@yue
2014年學術文章
@zh-hant
name
Quality-adjusted survival with ...... ic cancer: a Q-TWiST analysis.
@en
Quality-adjusted survival with ...... ic cancer: a Q-TWiST analysis.
@nl
type
label
Quality-adjusted survival with ...... ic cancer: a Q-TWiST analysis.
@en
Quality-adjusted survival with ...... ic cancer: a Q-TWiST analysis.
@nl
prefLabel
Quality-adjusted survival with ...... ic cancer: a Q-TWiST analysis.
@en
Quality-adjusted survival with ...... ic cancer: a Q-TWiST analysis.
@nl
P2093
P1476
Quality-adjusted survival with ...... ic cancer: a Q-TWiST analysis.
@en
P2093
Marc Botteman
Michele Reni
Scott Whiting
P304
P356
10.3111/13696998.2014.903122
P407
P577
2014-03-21T00:00:00Z